BioMarin Pharmaceutical (NASDAQ:BMRN) Earns “Sector Perform” Rating from Royal Bank of Canada
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report)‘s stock had its “sector perform” rating reissued by investment analysts at Royal Bank of Canada in a note issued to investors on Wednesday, Benzinga reports. They currently have a $80.00 target price on the biotechnology company’s stock. Royal Bank of Canada’s price objective indicates a potential upside of […]
More Stories
Short Interest in Theriva Biologics, Inc. (NYSEAMERICAN:TOVX) Decreases By 18.5%
Theriva Biologics, Inc. (NYSEAMERICAN:TOVX – Get Free Report) was the recipient of a large decline in short interest in October....
Presidio Property Trust, Inc. (NASDAQ:SQFTP) Declares $0.20 Dividend
Presidio Property Trust, Inc. (NASDAQ:SQFTP – Get Free Report) declared a dividend on Wednesday, October 30th, investing.com reports. Investors of...
Sequans Communications (NYSE:SQNS) Stock Rating Upgraded by StockNews.com
Sequans Communications (NYSE:SQNS – Get Free Report) was upgraded by stock analysts at StockNews.com from a “sell” rating to a...
NBT Bancorp (NASDAQ:NBTB) Upgraded to “Hold” at StockNews.com
NBT Bancorp (NASDAQ:NBTB – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “sell” rating to...
Algorand Hits 1-Day Volume of $22.54 Million (ALGO)
Algorand (ALGO) traded down 3.1% against the US dollar during the 24 hour period ending at 23:00 PM Eastern on...
Braemar Hotels & Resorts (NYSE:BHR) Downgraded to Sell Rating by StockNews.com
Braemar Hotels & Resorts (NYSE:BHR – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating...